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Abstract Circadian rhythms are recurring patterns in a
host of physiological and other parameters that recur with
periods of near 24 h. These rhythms reflect the temporal
organization of an organism’s homeostatic control systems
and as such are key processes in ensuring optimal physi-
ological performance. Dysfunction of circadian processes
is linked with adverse health conditions. In this review we
highlight the evidence that normal, healthy aging is asso-
ciated with changes in the circadian system; we examine
the molecular mechanisms through which such changes
may arise, discuss whether more robust circadian function
is a predictor of longevity and highlight the role of circa-
dian rhythms in age-related diseases. Overall, the literature
shows that aging is associated with marked changes in
circadian processes, both at the behavioral and molecular
levels, and the molecular mechanisms through which such
changes arise remain to be elucidated, but may involve
inflammatory process, redox homeostasis and epigenetic
modifications. Understanding the nature of age-related
circadian dysfunction will allow for the design of
chronotherapeutic intervention strategies to attenuate
circadian dysfunction and thus improve health and quality
of life.
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Introduction
The world population is inexorably aging (Ferrucci et al.
2008). Among the many societal and health challenges that
this situation poses is the need to understand how aging
impacts on circadian rhythms and sleep, in order to
delineate the impact that these changes may have on health
and wellbeing. Circadian rhythms are recurring cycles in a
host of physiological, biochemical and behavioral param-
eters that display periods of near 24 h (Dibner et al. 2010).
Contribution to the timing of the sleep/wake cycle is one of
the most prominent outputs of the circadian system and
there is a complex interplay between the circadian and the
homeostatic control systems in determining sleep onset and
duration (Franken 2013).
Circadian rhythms are internally generated by an
intrinsic circadian timekeeping system, which in turn
interacts with rhythmic stimuli in the environment to pro-
duce biologically salient rhythms. Given the large number
of mammalian processes that have been shown to be under
some type of circadian control, it should be of no great
surprise that clock dysfunction is linked with deleterious
health outcomes (Smolensky et al. 2015). This point is
further reinforced by consideration of the presence of
molecular clocks in the vast majority of mammalian tissues
and cell types, and the widespread influence of the clock on
gene expression (Koike et al. 2012). In this review we
discuss the evidence for circadian clock dysfunction in
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healthy aging, the impact of circadian timing for longevity
and how circadian dysfunction may contribute to deleteri-
ous health outcomes in older age.
Changes in circadian rhythms and sleep/wake
behavior associated with aging
Age has a marked effect on circadian rhythms and the
temporal organization of sleep/wake behaviors. A striking
example of this is alterations in the timing of sleep/wake
behaviors (termed chronotype) and how these change over
the developmental time course. Large-scale epidemiologi-
cal studies indicate that chronotype, as indicated by the
timing of the midpoint of sleep on non-work days, is pro-
foundly influenced by age, with infancy and childhood
being associated with early chronotype, adolescence with
late chronotype and older age with early chronotype
(Roenneberg et al. 2003). In terms of understanding the
physiological basis for these gross patterns in daily
behavior, analysis of older subjects under forced desyn-
chrony protocols that allow for the accurate assessment of
circadian rhythms, as opposed to sleep/wake rhythms,
reveals that the period of circadian rhythms in older people
does not differ from those in younger people (Czeisler et al.
1999). This finding indicates that the precision of the
intrinsic circadian timing is not overtly impacted by heal-
thy aging. However, numerous studies indicate that the
amplitude of circadian rhythms is progressively blunted in
healthy aging. This is manifested in a less clear demarca-
tion between consolidated periods of waking and sleep,
with more sleep episodes occurring in the day and more
waking occurring during the night (reviewed in Hofman
and Swaab 2006). Such disturbances may be of particular
importance for many functional domains; for example,
cognitive performance is predicted by circadian amplitude
in older participants (Oosterman et al. 2009). There may
also be altered phases of various rhythms in aging, with
core body temperature and melatonin secretion showing
altered phase (Duffy and Czeisler 2002; Yoon et al. 2003).
These results may indicate that the circadian systems are
less able to adjust to environmental time cues with age, and
as a result are more prone to desynchronisation (Arellanes-
Licea et al. 2014).
Anatomy and neurophysiology of the SCN
pacemaker and aging
Sleep is an active phenomenon that is controlled by var-
ious levels of the CNS (Stiller and Postolache 2005). The
centers that are implicated in the homeostatic regulation
of sleep state are located in the medulla oblongata, pons,
locus coeruleus, substantia nigra, the basal forebrain and
the hypothalamus (Stiller and Postolache 2005; Zeman
and Reading 2005). Interestingly these nuclei are under-
stood to be under the influence of the circadian system,
and further feedback onto that system (Moore, 2007). The
master circadian pacemaker of this system is located in
the suprachiasmatic nucleus (SCN) of the anterior
hypothalamus, which is a small bilateral structure located
directly dorsal to the optic chiasm, through which it
receives direct retinal innervations from intrinsically
photosensitive retinal ganglion cells (Saper et al. 2005).
The SCN then projects, mostly indirectly via other
hypothalamic relay stations, extensively throughout the
brain to control the phase of extra-SCN semi-autonomous
local CNS clocks (Saper et al. 2005; Guilding and Piggins
2007). Phase information is also conveyed from the CNS
to peripheral pacemakers through a complex mixture of
autonomic, endocrine and other physiological signals (e.g.
core body temperature) to ensure that that all of the
constituent pacemakers of this system have appropriate
phase-relationships; in other words, that there is internal
synchrony (Dibner et al. 2010).
So an obvious place to start when trying to understand
the nature of the mechanisms that give rise to alterations in
sleep/wake behavior in normal aging is to ask whether
there are anatomical and/or neurochemical variations that
occur within the master SCN pacemaker. A number of
studies have examined the SCN from post-mortem tissue
and reported that there are not major gross pathological
changes in the aged SCN; there is no evidence of marked
cell loss in the SCN during normal aging (Hofman and
Swaab 2006). Having said this, there is evidence for
alterations in distinct populations of neuropeptidergic
neurons in the SCN: cell numbers expressing arginine
vasopressin (AVP) do not show diurnal rhythms in older
subjects compared to the marked rhythms observed in
younger subjects (Hofman and Swaab 1994). Given a
recently demonstrated role for AVP in maintaining circa-
dian pacemaker resilience in the SCN (Yamaguchi et al.
2013), it is possible that alterations in SCN AVP produc-
tion in part underpin the altered circadian resetting
observed in older people and animals. Another key SCN
neuropeptide, vasoactive intestinal polypeptide (VIP), also
shows age-related changes. In males, aging is associated
with a decrease in VIP expression. VIP appears to play a
key role in the SCN neuronal network (Vosko et al. 2007)
and so alterations in VIP expression could be a key con-
tributor to circadian dysfunction in older age.
SCN expression of the MT1 melatonin receptor is also
diminished in healthy aging in the human SCN, indicating
that melatoninergic feedback to the SCN may be weakened
in aging (Wu et al. 2007). These findings are in agreement
with results from other similar studies that show that the
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SCN of aged rodents is less responsive to melatonin (Von
Gall and Weaver 2008). Aside from decreased SCN sen-
sitivity to melatonin, there is a considerable body of evi-
dence that suggests melatonin secretion by the pineal gland
is compromised by advancing age (Touitou 2001). In the
elderly there is on average a 50 % decline in nocturnal
melatonin levels, although there are high levels of inter-
individual variation (Touitou 2001). Increased wakening
after sleep onset, and concomitant increases in nocturnal
light exposure, could possibly explain such suppression,
especially given the recent suggestion that the human
melatoninergic system is more sensitive to suppression by
light than previously thought (Vartanian et al. 2015). A
recent cohort study of melatonin in an elderly population
has indicated that decreased 6-sulftoxymelatonin (a
metabolite of melatonin) was associated with declined
cognition and lower mood, and that these associations were
independent of each other (Obayashi et al. 2015a). Other
studies from the same cohort have indicated that higher
melatonin secretion is associated with decreased white
blood cell and platelet counts and with decreased arterial
stiffness (Obayashi et al. 2014, 2015b). These results
indicate that higher levels of melatonin secretion may be
protective for numerous physiological systems in aging.
Given that melatonin may exert anti-oxidant (Reiter et al.
2014) and anti-inflammatory actions (Hardeland et al.
2015), preserved functioning of the melatoninergic system
into older age may produce multiple physiological benefits.
Further, given the sleep-promoting properties of melatonin
(Zhdanova 2005), there is the possibility that aging is
associated with a vicious cycle. In such a cycle, weakened
SCN circadian output leads to diminished amplitude of the
sleep/wake cycle, more nocturnal awakening and more
nocturnal light exposure; this in turn decreases nocturnal
melatonin, lessens the feedback from melatonin back to the
SCN and thus propagates weakened SCN output. This in
turn would lead to more fragmented sleep, more sleep debt
and the consequences associated with that (such as alter-
ations in inflammatory mediators; Frey et al. 2007) against
a background in which some of the protection of melatonin
is lost due to age-related declines in its secretion and/or
diminished responsively of target tissues. Recently it was
suggested that the integrity of the cellular genome and
metabolic function can be influenced by light at night and
associated suppression of circadian melatonin production
(Belancio et al. 2015).
An optimal regime for the use of exogenous melatonin,
or melatoninergic agonists, to counter such effects in old
age has yet to be formulated and thoroughly investigated
(Vural et al. 2014).
Normal healthy aging is associated with low-grade
chronic neuroinflammation (‘‘inflammaging’’; Baylis et al.
2013) and alterations of inflammatory processes in the
hypothalamus have recently been shown to induce
remarkable senescence-resistant phenotypes (Zhang et al.
2013a). Neuroinflammation within the aged SCN may
therefore play a role in aging-related circadian dysfunction.
SCN from older rodents has been shown to demonstrate
elevated levels of microglial and astrocytic activation
(Deng et al. 2010). Further aging has been associated with
changes in SCN cytokine and cytokine receptor levels
(Beynon and Coogan 2010; Beynon et al. 2009). Given that
proinflammatory mediators such as tumor necrosis factor a
(TNF-a) and interferon-g (IFN-c) can alter SCN neuronal
function (Kwak et al. 2008; Nyga˚rd et al. 2009) and can
alter circadian phase (Duhart et al. 2013; Paladino et al.
2014), there may be a role for age-related neuroinflam-
mation in age-associated clock dysfunction. The induction
of chronic neuroinflammation that persists following sepsis
is also associated with altered circadian functioning, some
facets of which (e.g. altered phase resetting) appear to
resemble those reported in aged animal models (O’Cal-
laghan et al. 2012). Further evidence for such a mechanism
comes from drosophila models of Alzheimer’s disease,
wherein there are significant impacts on circadian rhythms
in behavior, even though central clock neurons are spared
(Long et al. 2014). These findings suggest that in these
models a synaptic pathology, possibly associated with
increased inflammation, is important in mediating the
impairment of circadian rhythms in behavioral output,
rather than behavioral impairment being a function of clock
neuron dysfunction.
Given that aging is not associated with marked neu-
ronal loss or other neuropathology in the SCN, it is
important to note that several studies indicate that aging is
associated with substantial alterations in SCN neuro-
physiology. SCN neurons normally show rhythms in their
electrophysiological discharge rates in a neurochemical
phenotype-dependent manner (Belle et al. 2009). The
pattern of firing appears to be important physiological
outputs of the SCN, and in the aged SCN there is a
blunting of this rhythmic output (Farajnia et al. 2012;
Nakamura et al. 2011; Watanabe et al. 1995). These
changes in SCN output may be reflective of changes in the
inter-neuronal coupling of the SCN network, a hypothesis
that would be in keeping with the above-mentioned
changes in neuropeptides in the aged SCN. Further, there
have been descriptions of age-related changes in the
GABAergic SCN (Palomba et al. 2008) as well as changes
in responsiveness to glutamate, histamine and GABAergic
stimulation (Biello 2009). The overall finding appears to
be that the amplitude of SCN output decreases with age,
perhaps through weakening of the SCN network and intra-
oscillator coupling (Farajnia et al. 2014); such an effect is
consistent with the behavioral findings of dampened
rhythm amplitudes in older age.
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Clock genes and aging
The discovery of the molecular clocks that control cell
activity has expanded our understanding of physiology and
behavior. However, the rhythmic mechanisms by which
transcriptional signals can coordinate behavioral and
physiological processes are not yet fully elucidated (Cho
et al. 2012). The circadian clock generates the circadian
rhythm and involves a panel of clock genes whose basic
properties are conserved from flies to humans (Hardin,
2011). In most mammals, nearly all the cells and organs
exhibit circadian modulation of gene expression (Dibner
et al. 2010). However, the mechanisms underlying age-
related decay of the circadian system are still not well
understood. The circadian rhythm is driven by a molecular
clock involving a transcriptional negative-feedback loop.
The canonical genes involved in the molecular system of
the mammalian circadian clock include the Circadian
Locomotor Output Cycles Kaput gene (clock), the Brain
and Muscle ARNT-like protein 1 encoding gene (bmal1),
Period genes (per1, per2 and per3), Cryptochrome (cry1
and cry2), and rev-erb-a (Nagoshi et al. 2010; Parish 2013;
Rakshit and Giebultowicz 2013). The basic intrinsic
mechanisms involve BMAL1 protein forming a hetero-
dimeric complex with CLOCK (or NPAS2), which in turn
drives the transcription of the per and cry genes and con-
sequently increases PER and CRY protein levels. PER and
CRY proteins are released from the nucleus into the
cytoplasm where they form PER/CRY heterodimers. When
the PER/CRY heterodimer concentration reaches the crit-
ical level they move back into the nucleus and acts as
negative regulators of BMAL1-CLOCK/NPAS2 hetero-
dimer, thereby inhibiting its own protein synthesis (PER/
CRY inhibitory feedback loop) (Dibner et al. 2010).
Another two proteins have been described to modulate
bmal1 gene expression. These proteins are represented by
nuclear receptor subfamily 1 group D member 1 (nr1d1,
also known as rev-erba) and ROR-related orphan receptor
1 (ror1). Expression of rev-erba and ror is driven by the
CLOCK:BMAL1 complex, and feeds back onto bmal1
expression, adding a second feedback loop to the system.
The clock gene cycle ultimately influences cellular physi-
ology by regulating rhythmic expression of clock-con-
trolled genes, in a tissue specific manner (Panda et al.
2002). Recent analysis has revealed that circadian control
of the transcriptional landscape is surprisingly widespread
and highly complex, and that non-transcriptional processes
also play key roles in generating rhythmic molecular output
(Koike et al. 2012).
A number of studies have examined the effects of aging
on clock gene expression in various tissues. Middle age in
mice was reported to be associated with alterations in the
amplitude and/or phase of expression of the CLOCK and
BMAL1 proteins in the SCN, hippocampus, amygdala and
the paraventricular, arcuate and dorsomedial nuclei of the
hypothalamus (Wyse and Coogan, 2010). Similar findings
are reported for expression of mRNA for bmal1 and per2 in
non-SCN brain regions in older hamsters (Duncan et al.
2013). Further analysis of rhythmic clock gene expression
patterns during aging shows that the SCN shows changes in
rev-erb a, dec1 and the clock-controlled gene dbp, and that
heart and liver clocks also show significant changes in
rhythmic clock gene expression (Bonaconsa et al. 2014).
Aging does not seem to be associated with catastrophic loss
of molecular rhythmicity in the SCN, as aged mice show a
dampened rhythm of per2 but an unaltered rhythm of per1
(Weinert et al. 2001). Further, per1 rhythms are not altered
in the aged rat and hamster SCN (Asai et al. 2001; Kolker
et al. 2003). The use of circadian clock gene reporter
systems has further elucidated the impact of aging on
molecular rhythms. Per1:luc rats show modest age-related
changes in SCN rhythms, while peripheral oscillators show
more profound changes in per1 expression (Yamazaki et al.
2002). A further study using Per1:luc rats show that the
rates of re-entrainment of peripheral oscillators to a phase-
shift are altered with age, while the rate of SCN resetting is
not altered (Davidson et al. 2008). Such a result may
indicate that the mechanism through which phase infor-
mation is conveyed from the central clock to peripheral
clocks is altered with aging and such a mechanism may
contribute to desynchronisation of constituent pacemakers
of the circadian system; it is this desynchronisation that
may underpin the deleterious effects of age-related circa-
dian dysfunction.
There are obvious difficulties in the examination of
clock gene expression cycles in human tissue, especially
CNS tissue. Examination of post-mortem tissue has
revealed that there are circadian rhythms of PER2, PER3
and BMAL1 in the cerebral cortices of the study partici-
pants who had a mean age of *85 years, indicating that
rhythmic expression persists in cortical areas into old age
(Lim et al. 2013). Examination of clock gene expression
patterns in leukocytes reveals that there are rhythms in
PER1, 2, 3 present in older participants, although the
phases of these rhythms are altered compared to younger
subjects (Hida et al. 2009). Aged subjects also appear to
show changes in circadian patterns in lymphocyte sub-
populations, demonstrating that circadian effects of aging
may translate into immunological changes (Mazzoccoli
et al. 2011).
Via which mechanism might clock gene expression be
modulated in aging? Recent studies have focused on the
cross talk between the circadian and metabolic control
systems to identify modulators that may be of importance in
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aging. One such mediator is SIRT1. SIRT1 impacts on the
central circadian clock in the brain by activating the tran-
scription of the two major circadian regulators, bmal1 and
clock. SIRT1 action involves another two players, peroxi-
some proliferator-activated receptor gamma coactivator
1-alpha (PGC-1a) that is encoded peroxisome proliferator-
activated receptor gamma coactivator 1 (ppargc1) gene and
nicotinamide phosphoribosyltransferase (NAMPT) (Ram-
sey et al. 2009; Chang and Guarente 2013). SIRT1 and
PGC-1 a form a regulatory complex that integrates the
mammalian clock, energy metabolism, cellular stress and
lipid metabolism (Liu et al. 2007; Wang and Lung 2012).
PGC-1 a stimulates the expression of the clock genes,
bmal1 and rev-erb-a, through coactivation of the ROR
family receptors. In aged, wild-type mice, SIRT1 level in
the SCN is decreased concomitantly with levels of BMAL1
and PER2 (Chang and Guarente 2013). Further, older ani-
mals show altered free-running period, entrainment and
phase resetting. Intriguingly, sirt1 knockout results in a
senescent-like phenotype on these circadian parameters,
while sirt1 over-expression results in an anti-aging pheno-
type in terms of circadian changes (Chang and Guarente
2013). SIRTs are also proposed to contribute to epigenetic
changes that occur in the clock with aging (Orozco-Solis
and Sassone-Corsi 2014). Aging has been shown to impact
on clock gene methylation in various peripheral tissues
(Zhang et al. 2013b). Another signaling pathway that may
be involved in age-related epigenetic clock modifications is
the mTOR cascade, as mTOR is associated with cellular
senescence (Orozco-Solis and Sassone-Corsi 2014) and is
also associated with clock function (Cao et al. 2011, 2013);
therefore it may play a role in linking the clock to aging
(Khapre et al. 2014).
Circadian rhythm and healthy aging
There are a number of lines of evidence that suggest that
proper circadian function is important in healthy aging.
Firstly there is evidence based on the circadian resonance
theory which hypothesizes that the environmental cycles
that animals are exposed to should display periods that best
match the period of the intrinsic circadian pacemaker for
optimal physiological outcomes. This hypothesis is sup-
ported by evidence pertaining to the association between
free-running period and longevity, with deviation of free-
running period (the length of the circadian cycle expressed
in constant environmental conditions) away from 24 h
being associated with shorter life spans in different rodent
species and mouse strains (Wyse et al. 2010). Further
support from this idea comes from experimental studies
examining free-running periods of individual mice, which
show that the free-running periods closer to 24 h are
associated with greater longevity (Libert et al. 2012).
Interestingly, the tau mutant hamster, which has a free-
running period of *20 h, shows enhanced longevity
compared to wild types when housed in constant dim red
light (Oklejewicz and Daan 2002), while a previous study
had indicated that heterozygous tau mutant animals (with a
period of about 22 h) housed under a 12:12 light:dark cycle
showed reduced longevity (Hurd and Ralph 1998). Con-
verse findings are reported for the long-lived MUPA mouse
which displays circadian free-running periods of 24 h at
both young and older ages, compared to the wild-type
controls whose periods deviate from 24 h (Gutman et al.
2011). These findings may indicate that it is not the devi-
ation of the period from 24 h per se that is important, rather
the mismatch between the circadian period and the period
of the imposed light/dark cycle. Other studies have shown
that an abrupt phase-advance of the light dark cycle can
induce remarkable mortality in aged rats and mice
(Davidson et al. 2006, 2008), indicating that as the circa-
dian system ages it becomes very sensitive to acute large
perturbations.
There is also evidence that clock genes may play
important roles in healthy aging aside from their roles in
dictating functional circadian rhythms. Mice deficient in
clock genes show impaired average and maximum life
spans: for example, the clock knockout mouse shows a
15 % reduction in average life span (Dubrovsky et al.
2010). The clock gene bmal1 is the only obligate mam-
malian clock gene for behavioral rhythmicity, with bmal1
knockout animals showing no circadian rhythms under
free-running conditions (Bunger et al. 2000). These ani-
mals also show a remarkably severe accelerated aging
phenotype (Kondratov et al. 2006). This phenotype
includes cataract development, sarcopenia, leanness and
very premature mortality (an average life span of only
37 weeks; Kondratov et al. 2006). Bmal1 has been shown
to be involved in redox homeostasis, and its knockout
results in profound astrogliosis in the brain and neurode-
generation, independent of the loss of circadian rhythms in
behavior (Musiek et al. 2013). Bmal1 also interacts with
the NF-jB signaling system, and it has been proposed that
bmal1 knockout results in a chronic inflammatory state that
contributes to the accelerated aging phenotype (Spengler
et al. 2012).
Circadian rhythms in age-related diseases
Circadian rhythm and sleep disturbances are described as
being prominent in a number of chronic, age-related
conditions. These include Alzheimer’s disease (Coogan
et al. 2013), age-related cognitive decline and mild cog-
nitive impairment (Cochrane et al. 2012; Ortiz-Tudela
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et al. 2014; Naismith et al. 2014), Parkinson’s disease
(Breen et al. 2014), rheumatoid arthritis (De Cata et al.
2014), type II diabetes mellitus (Rakshit et al. 2014) and
cancer (Palesh et al. 2014). Further circadian rhythm
disturbances are reported in a number of life-long psy-
chiatric conditions such as schizophrenia (Wulff et al.
2012), bipolar disorder (Robillard et al. 2013) and adult
attention deficit hyperactivity disorder (Baird et al. 2012).
Age may also play an important role in linking circadian
disruption to mood disorders, such that the nature of the
circadian rhythms observed, for example, in young
patients with major depression may differ markedly from
those in older patients with major depression (Campos
Costa et al. 2013). An interesting facet is that circadian
and/or sleep disturbances may be prodromal signs of
common illnesses of old age. This possibility was high-
lighted in a prospective cohort study which demonstrated
that circadian rhythm changes in locomotion are signifi-
cant predictors of subsequent dementia or mild cognitive
impairment (Tranah et al. 2011). Such sub-clinical chan-
ges may represent novel diagnostic opportunities that
allow for early intervention. In terms of delivering
chronotherapeutic interventions to ameliorate circadian
dysfunction, it is important to appreciate the nature of the
dysfunction first. As healthy aging and, in a more exag-
gerated manner, neurodegenerative disorders are accom-
panied by marked dampening of circadian amplitude and
rhythm fragmentation, chronotherapeutic interventions
that involve strengthened zeitgebers may prove most
effective. The use of brighter lights in nursing home day
rooms has already been shown to be effective in slowing
cognitive decline (Riemersa-van der Lek et al. 2008).
Other interventions, such as scheduled exercise, may also
prove effective and there is good evidence from pre-
clinical models for this strategy (Leise et al. 2013; Power
et al. 2010). For other conditions, such as mood disorders,
the most notable circadian changes are those in phase and
desynchronisation of output rhythms, and such changes
suggest that the most fruitful approaches will involve
chronotherapy that reset clock phase (Coogan and Thome
2011).
Conclusion
We have outlined evidence above that illustrates the fas-
cinating, bidirectional relationship between aging and the
circadian system. As the world population thankfully
continues to live longer, understanding how the circadian
system may be manipulated by environmental, behavioral
and pharmacological interventions to increase health in old
age and attenuate the development and severity of chronic
illnesses becomes more important, and this in turn signals a
pressing need for more research focussed on this important
question.
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